Athanase Innovation AB (OSTO:ATIN) ROE %: 108.32% (As of Dec. 2020)


OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr17.80
View Full Analysis

What is Athanase Innovation AB ROE %?

Athanase Innovation AB OSTO:ATIN 26 ROE % is 108.32% as of Dec. 2020. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Athanase Innovation AB's annualized net income for the quarter that ended in Dec. 2020 was kr347.07 Mil. Athanase Innovation AB's average Total Stockholders Equity over the quarter that ended in Dec. 2020 was kr320.41 Mil. Therefore, Athanase Innovation AB's annualized ROE % for the quarter that ended in Dec. 2020 was 108.32%.

The historical rank and industry rank for Athanase Innovation AB's ROE % or its related term are showing as below:

OSTO:ATIN's ROE % is not ranked *
in the Asset Management industry.
Industry Median: 6.52
* Ranked among companies with meaningful ROE % only.

Athanase Innovation AB  (OSTO:ATIN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2020 )
=Net Income/Total Stockholders Equity
=347.066/320.405
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(347.066 / 0.704)*(0.704 / 540.2955)*(540.2955 / 320.405)
=Net Margin %*Asset Turnover*Equity Multiplier
=49299.15 %*0.0013*1.6863
=ROA %*Equity Multiplier
=64.09 %*1.6863
=108.32 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2020 )
=Net Income/Total Stockholders Equity
=347.066/320.405
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (347.066 / 347.64) * (347.64 / -2.282) * (-2.282 / 0.704) * (0.704 / 540.2955) * (540.2955 / 320.405)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9983 * -152.3401 * -324.15 % * 0.0013 * 1.6863
=108.32 %

Note: The net income data used here is two times the semi-annual (Dec. 2020) net income data. The Revenue data used here is two times the semi-annual (Dec. 2020) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Athanase Innovation AB ROE % Related Terms


Athanase Innovation AB ROE % Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB ROE % Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
ROE %
0.00 2.52 2.35

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
ROE % Get a 7-Day Free Trial 2.12 2.69 1.90 3.14 108.32

OSTO:ATIN vs EVG, SMM, NHS: ROE % Comparison

For the Asset Management subindustry, Athanase Innovation AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athanase Innovation AB ROE % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's ROE % distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's ROE % falls into.


OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB ROE % Calculation

Athanase Innovation AB's annualized ROE % for the fiscal year that ended in Jun. 2019 is calculated as

ROE %=Net Income (A: Jun. 2019 )/( (Total Stockholders Equity (A: Jun. 2018 )+Total Stockholders Equity (A: Jun. 2019 ))/ count )
=6.304/( (276.689+260.433)/ 2 )
=6.304/268.561
=2.35 %

Athanase Innovation AB's annualized ROE % for the quarter that ended in Dec. 2020 is calculated as

ROE %=Net Income (Q: Dec. 2020 )/( (Total Stockholders Equity (Q: Jun. 2020 )+Total Stockholders Equity (Q: Dec. 2020 ))/ count )
=347.066/( (244.062+396.748)/ 2 )
=347.066/320.405
=108.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2020) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 108.32% mean?
Athanase Innovation AB (OSTO:ATIN) has a ROE % of 108.32% as of Dec. 2020. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's ROE % too high?
Athanase Innovation AB's current ROE % is 108.32%. The Asset Management industry median ROE % is 6.52. Athanase Innovation AB's value of 108.32% is 1561.3% above this industry median. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's ROE % compare to EVG and SMM?
Athanase Innovation AB's ROE % of 108.32% can be compared against companies in the Asset Management industry. The industry median ROE % is 6.52. Athanase Innovation AB's value of 108.32% is 1561.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Asset Management company?
The median ROE % among Asset Management companies is 6.52, based on 1,609 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athanase Innovation AB's current ROE % of 108.32% is 1561.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Athanase Innovation AB and its competitors. For the Asset Management industry, the median ROE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current ROE % is 108.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current ROE % of 108.32%. The current ROE % is 108.32% and 1561.3% above the Asset Management industry median of 6.52. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current ROE % is 108.32% as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.80
Price